Found: 73
Select item for more details and to access through your institution.
Fragment size and dynamics of EGFR-mutated tumor-derived DNA provide prognostic information regarding EGFR-TKI efficacy in patients with EGFR-mutated NSCLC.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-17848-y
- By:
- Publication type:
- Article
Osimertinib versus standard-of-care EGFR-TKI as first-line treatment for EGFRm advanced NSCLC: FLAURA Japanese subset.
- Published in:
- Japanese Journal of Clinical Oncology, 2019, v. 49, n. 1, p. 29, doi. 10.1093/jjco/hyy179
- By:
- Publication type:
- Article
Phase 3 study of ceritinib vs chemotherapy in ALK-rearranged NSCLC patients previously treated with chemotherapy and crizotinib (ASCEND-5): Japanese subset.
- Published in:
- Japanese Journal of Clinical Oncology, 2018, v. 48, n. 4, p. 367, doi. 10.1093/jjco/hyy016
- By:
- Publication type:
- Article
Characteristics and overall survival of EGFR mutation-positive non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors: a retrospective analysis for 1660 Japanese patients.
- Published in:
- Japanese Journal of Clinical Oncology, 2016, v. 46, n. 5, p. 462, doi. 10.1093/jjco/hyw014
- By:
- Publication type:
- Article
Epstein-Barr virus-associated post-transplant lymphoproliferative disorders after allogeneic peripheral blood stem cell transplantation for Hodgkin-like adult T-cell leukemia/lymphoma.
- Published in:
- 2012
- By:
- Publication type:
- Report
Quality of life and survival survey of cancer cachexia in advanced non-small cell lung cancer patients-Japan nutrition and QOL survey in patients with advanced non-small cell lung cancer study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
rho-mediated protein tyrosine phosphorylation in lysophosphatidic-acid-induced tumor-cell invasion.
- Published in:
- International Journal of Cancer, 1996, v. 65, n. 5, p. 627, doi. 10.1002/(SICI)1097-0215(19960301)65:5<627::AID-IJC12>3.0.CO;2-4
- By:
- Publication type:
- Article
Pleural sarcoidosis diagnosed on the basis of an increased CD4/CD8 lymphocyte ratio in pleural effusion fluid: a case report.
- Published in:
- Journal of Medical Case Reports, 2015, v. 9, n. 1, p. 1, doi. 10.1186/s13256-015-0656-y
- By:
- Publication type:
- Article
Pleural sarcoidosis diagnosed on the basis of an increased CD4/CD8 lymphocyte ratio in pleural effusion fluid: a case report.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Preoperative AminoIndex Cancer Screening (AICS) abnormalities predict postoperative recurrence in patients undergoing curative resection for non-small cell lung cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A phase I/II study of weekly nab-paclitaxel plus cisplatin in chemotherapy-naïve patients with advanced non-small-cell lung cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Differential significance of molecular subtypes which were classified into EGFR exon 19 deletion on the first line afatinib monotherapy.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Phase 2 study of bevacizumab plus carboplatin/nab-paclitaxel followed by bevacizumab plus nab‐paclitaxel for non‐squamous non‐small cell lung cancer with malignant pleural effusion.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 4, p. 1106, doi. 10.1007/s10637-021-01076-8
- By:
- Publication type:
- Article
Successful treatment of an osimertinib-resistant lung adenocarcinoma with an exon 18 EGFR mutation (G719S) with afatinib plus bevacizumab.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 1, p. 232, doi. 10.1007/s10637-020-00966-7
- By:
- Publication type:
- Article
Phase I study of TAS-121, a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, in patients with non-small-cell lung cancer harboring EGFR mutations.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 6, p. 1207, doi. 10.1007/s10637-019-00732-4
- By:
- Publication type:
- Article
Proliferative CD8(+) PD-1(+) T-cell infiltration in a pembrolizumab-induced cutaneous adverse reaction.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 6, p. 1138, doi. 10.1007/s10637-018-0628-3
- By:
- Publication type:
- Article
Involvement of small GTPases Rho and Rac in the invasion of rat ascites hepatoma cells.
- Published in:
- Clinical & Experimental Metastasis, 1999, v. 17, n. 2, p. 141, doi. 10.1023/A:1006598531238
- By:
- Publication type:
- Article
Japanese subgroup analysis of a phase III study of S-1 versus docetaxel in non-small cell lung cancer patients after platinum-based treatment: EAST-LC.
- Published in:
- International Journal of Clinical Oncology, 2019, v. 24, n. 5, p. 485, doi. 10.1007/s10147-019-01396-z
- By:
- Publication type:
- Article
Aprepitant for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy.
- Published in:
- International Journal of Clinical Oncology, 2017, v. 22, n. 3, p. 600, doi. 10.1007/s10147-016-1081-y
- By:
- Publication type:
- Article
High-Dose-Rate Brachytherapy for Small-Sized Peripherally Located Lung Cancer.
- Published in:
- Strahlentherapie und Onkologie, 2006, v. 182, n. 12, p. 703, doi. 10.1007/s00066-006-1536-6
- By:
- Publication type:
- Article
Clinical Experience with Autofluorescence Imaging System in Patients with Lung Cancers and Precancerous Lesions.
- Published in:
- Respiration, 2007, v. 74, n. 3, p. 304, doi. 10.1159/000093233
- By:
- Publication type:
- Article
Analysis of Early Death in Japanese Patients With Advanced Non-small-cell Lung Cancer Treated With Nivolumab.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Novel Chemoradiotherapy With Concomitant Boost Thoracic Radiation and Concurrent Cisplatin and Vinorelbine for Stage IIIA and IIIB Non-Small-Cell Lung Cancer.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Novel Chemoradiotherapy With Concomitant Boost Thoracic Radiation and Concurrent Cisplatin and Vinorelbine for Stage IIIA and IIIB Non--Small-Cell Lung Cancer.
- Published in:
- Clinical Lung Cancer, 2014, v. 15, n. 4, p. 281, doi. 10.1016/j.cllc.2014.02.001
- By:
- Publication type:
- Article
Polymorphisms of CYP2D6 Gene and Gefitinib-Induced Hepatotoxicity.
- Published in:
- Clinical Lung Cancer, 2013, v. 14, n. 5, p. 502, doi. 10.1016/j.cllc.2013.03.003
- By:
- Publication type:
- Article
Transient appearance of circulating tumor DNA associated with de novo treatment.
- Published in:
- Scientific Reports, 2016, p. 38639, doi. 10.1038/srep38639
- By:
- Publication type:
- Article
Numerical indices based on circulating tumor DNA for the evaluation of therapeutic response and disease progression in lung cancer patients.
- Published in:
- Scientific Reports, 2016, p. 29093, doi. 10.1038/srep29093
- By:
- Publication type:
- Article
Author Correction: Candidate mechanisms of acquired resistance to first-line osimertinib in EGFR-mutated advanced non-small cell lung cancer.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Quantitative Identification of Mutant Alleles Derived from Lung Cancer in Plasma Cell-Free DNA via Anomaly Detection Using Deep Sequencing Data.
- Published in:
- PLoS ONE, 2013, v. 8, n. 11, p. 1, doi. 10.1371/journal.pone.0081468
- By:
- Publication type:
- Article
Plasma Free Amino Acid Profiling of Five Types of Cancer Patients and Its Application for Early Detection.
- Published in:
- PLoS ONE, 2011, v. 6, n. 9, p. 1, doi. 10.1371/journal.pone.0024143
- By:
- Publication type:
- Article
Pemetrexed and carboplatin followed by pemetrexed maintenance therapy in chemo-naïve patients with advanced nonsquamous non-small-cell lung cancer.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Erratum to: Pemetrexed and carboplatin followed by pemetrexed maintenance therapy in chemo-naïve patients with advanced nonsquamous non-small-cell lung cancer.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Pemetrexed and carboplatin followed by pemetrexed maintenance therapy in chemo-naïve patients with advanced nonsquamous non-small-cell lung cancer.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 5, p. 1275, doi. 10.1007/s10637-013-9941-z
- By:
- Publication type:
- Article
Erratum to: Pemetrexed and carboplatin followed by pemetrexed maintenance therapy in chemo-naïve patients with advanced nonsquamous non-small-cell lung cancer.
- Published in:
- 2013
- By:
- Publication type:
- Correction Notice
Genome analysis of peeling archival cytology samples detects driver mutations in lung cancer.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 13, p. 4501, doi. 10.1002/cam4.3089
- By:
- Publication type:
- Article
Pretreatment advanced lung cancer inflammation index (ALI) for predicting early progression in nivolumab-treated patients with advanced non-small cell lung cancer.
- Published in:
- Cancer Medicine, 2018, v. 7, n. 1, p. 13, doi. 10.1002/cam4.1234
- By:
- Publication type:
- Article
Different spatial distributions of brain metastases from lung cancer by histological subtype and mutation status of epidermal growth factor receptor.
- Published in:
- Neuro-Oncology, 2016, v. 18, n. 5, p. 716, doi. 10.1093/neuonc/nov266
- By:
- Publication type:
- Article
Randomized Phase II trial of paclitaxel and carboplatin followed by gemcitabine switch-maintenance therapy versus gemcitabine and carboplatin followed by gemcitabine continuation-maintenance therapy in previously untreated advanced non-small cell lung cancer
- Published in:
- BMC Research Notes, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1756-0500-6-3
- By:
- Publication type:
- Article
Quantitative detection of ALK fusion breakpoints in plasma cell-free DNA from patients with non-small cell lung cancer using PCR-based target sequencing with a tiling primer set and two-step mapping/alignment.
- Published in:
- PLoS ONE, 2019, v. 14, n. 9, p. 1, doi. 10.1371/journal.pone.0222233
- By:
- Publication type:
- Article
Y-27632, an Inhibitor of Rho-associated Protein Kinase, Suppresses Tumor Cell Invasion via Regulation of Focal Adhesion and Focal Adhesion Kinase.
- Published in:
- Cancer Science, 2000, v. 91, n. 8, p. 811, doi. 10.1111/j.1349-7006.2000.tb01018.x
- By:
- Publication type:
- Article
Inhibition of in vitro Tumor Cell Invasion by Ginsenoside Rg<sub>3</sub>.
- Published in:
- Cancer Science, 1996, v. 87, n. 4, p. 357, doi. 10.1111/j.1349-7006.1996.tb00230.x
- By:
- Publication type:
- Article
Serum Requirement for in vitro Invasion by Tumor Cells.
- Published in:
- Cancer Science, 1991, v. 82, n. 5, p. 493, doi. 10.1111/j.1349-7006.1991.tb01877.x
- By:
- Publication type:
- Article
Diagnostic Accuracy of Noninvasive Genotyping of EGFR in Lung Cancer Patients by Deep Sequencing of Plasma Cell-Free DNA.
- Published in:
- Clinical Chemistry, 2015, v. 61, n. 9, p. 1191, doi. 10.1373/clinchem.2015.241414
- By:
- Publication type:
- Article
A Retrospective Study of the Novel Combination of Paclitaxel and S1 for Pretreated Advanced Non-Small Cell Lung Cancer.
- Published in:
- Chemotherapy (0009-3157), 2013, v. 58, n. 6, p. 454, doi. 10.1159/000345624
- By:
- Publication type:
- Article
Randomized Phase II Study of Two Schedules of Carboplatin and Gemcitabine for Stage IIIB and IV Advanced Non-Small Cell Lung Cancer (JACCRO LC-01 Study).
- Published in:
- Chemotherapy (0009-3157), 2011, v. 57, n. 4, p. 357, doi. 10.1159/000330481
- By:
- Publication type:
- Article
A Phase II Study Directed by a Clinical Pathway for Carboplatin and Weekly Paclitaxel in Previously Untreated Patients with Unresectable Non-Small Cell Lung Cancer.
- Published in:
- Chemotherapy (0009-3157), 2010, v. 56, n. 1, p. 39, doi. 10.1159/000287355
- By:
- Publication type:
- Article
Impact of in vitro chemosensitivity test-guided platinum-based adjuvant chemotherapy on the surgical outcomes of patients with p-stage IIIA non-small cell lung cancer that underwent complete resection.
- Published in:
- Molecular & Clinical Oncology, 2017, v. 7, n. 3, p. 327, doi. 10.3892/mco.2017.1340
- By:
- Publication type:
- Article
Protein and mRNA expression of folic acid-associated enzymes as biomarkers for the cytotoxicity of the thymidylate synthase-targeted drugs, pemetrexed and S-1, in non-small cell lung cancer.
- Published in:
- Molecular & Clinical Oncology, 2017, v. 7, n. 1, p. 15, doi. 10.3892/mco.2017.1262
- By:
- Publication type:
- Article
Inhibition of tumor invasion and metastasis by a novel lysophosphatidic acid (cyclic LPA).
- Published in:
- International Journal of Cancer, 1999, v. 81, n. 6, p. 918, doi. 10.1002/(SICI)1097-0215(19990611)81:6<918::AID-IJC13>3.0.CO;2-E
- By:
- Publication type:
- Article
Interactions of Lung Cancer Cells with the Human Mesothelial Cell Monolayer: An in Vitro Model for Cancer Invasion.
- Published in:
- Japanese Journal of Clinical Oncology, 1992, v. 22, n. 2, p. 67
- By:
- Publication type:
- Article